Collectively, these findings indicate that genetic variants that abolish ANGPTL4 function are associated with improved insulin sensitivity and glucose homeostasis and reduced risk of type 2 diabetes in humans. Here, ANGPTL4 is linked to type 2 diabetes mellitus.